Valuation : InspireMD, Inc.

Market Cap 42.24M 36.43M 34.27M 31.22M 58.71M 4.01B 59.03M 405M 158M 2.04B 159M 155M 6.76B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 42.24M 36.43M 34.27M 31.22M 58.71M 4.01B 59.03M 405M 158M 2.04B 159M 155M 6.76B EV / Sales 2026 *
4.31x
EV / Sales 2027 * 2.1x
Free-Float
80.03%
Yield 2026 *
-
Yield 2027 * -
1 day+1.99%
1 week-1.27%
Current month+1.99%
1 month+39.77%
3 months-8.23%
6 months-48.96%
Current year-48.96%
1 week 0.83
Extreme 0.83
0.95
1 month 0.65
Extreme 0.650001
1.02
Current year 0.63
Extreme 0.63
1.98
1 year 0.63
Extreme 0.63
2.56
3 years 0.63
Extreme 0.63
3.85
5 years 0.63
Extreme 0.63
5.06
10 years 0.63
Extreme 0.63
115,237.62
Manager TitleAgeSince
Chief Executive Officer 62 2019-12-31
Director of Finance/CFO 58 2025-06-24
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 2017-06-01
Director/Board Member 68 2013-02-06
Director/Board Member 62 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/27/26 Buy

Chairman

20,000 0.0427%
5/27/26
Osiris Investment Partners LLC
OtherCompany 0 0% -
5/19/26 Sell

Executive/Senior Manager

-22,778 0.0486%
Change 5-day change 1-year change 3-year change Capi.($)
+1.99%-1.27%-62.77%-73.67% 42.24M
-1.98%-3.99%-18.91%+11.58% 122B
-1.85%-1.96%-23.75%-0.47% 12.18B
-1.59%-2.59%+84.41%+135.95% 10.42B
+1.11%+0.52%-52.34%-70.07% 4.21B
-1.07%-9.48%-25.73%+36.87% 2.49B
+0.53%-1.31% - - 2.01B
-2.33%+0.74%-34.34%-74.24% 1.78B
-0.07%-2.79%-19.18%-23.16% 1.6B
Average -0.58%-2.39%-19.07%-7.15% 17.39B
Weighted average by Cap. -1.80%-3.46%-13.54%+15.83%

Financials

2026 *2027 *
Net sales 9.8M 8.45M 7.95M 7.24M 13.62M 930M 13.7M 94M 36.59M 473M 36.79M 35.99M 1.57B 20.13M 17.37M 16.34M 14.88M 27.98M 1.91B 28.14M 193M 75.16M 972M 75.59M 73.95M 3.22B
Net income - -
Net Debt - -
Logo InspireMD, Inc.
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Employees
127
Date Price Change Volume
26-09-01 US$0.9085 +1.99% 45,767
26-08-31 US$0.8908 +4.80% 72,908
26-08-28 US$0.8500 -4.35% 74,275
26-08-27 US$0.8887 -0.15% 23,318
26-08-26 US$0.8900 -3.28% 35,211
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.9085USD
Average target price
3.333USD
Spread / Average Target
+266.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NSPR Stock